Overcoming old paradigms in science can often take decades. Learn how Dr Vishawanath Lingappa fast tracked his “against-the-herd” discovery of self-assembly of viruses and the creation of a new subfield of molecular biology. He will bring his lively role as an internationally known speaker and scientist to the MITCNC Life Science forum. Dr Lingappa will focus his talk on three broad areas:
1) The pursuit of scientific knowledge and the trials and tribulations of developing truly new paradigms.
2) The journey from academic physician and Professor at UCSF to Founder and CEO of a for-profit biotech company, Prosetta.
3) Prosetta’s current translational research: clinical applications from basic scientific discoveries to clinical development of truly novel therapies.
Vishwanath R. Lingappa is currently CTO and Co-CEO of Prosetta Antiviral, Inc, in San Francisco. In these roles he is responsible for the advancement of Prosetta’s scientific programs in both anti-viral drug development and protein bioconformatics. He received a B.A. from Swarthmore College in 1975, a Ph.D. from The Rockefeller University in 1979, and an M.D. from Cornell University Medical College in 1980. Dr. Lingappa joined the faculty of UCSF in 1982, where he ran an NIH-funded basic research laboratory for over 20 years and he has practiced internal medicine at SF General Hospital for over 26 years.
Dr. Lingappa has co-authored over 90 publications. He maintains voluntary positions as Senior Scientist at the Research Institute of California Pacific Medical Center and Emeritus Professor of Physiology at UCSF. He is recipient of a Kaiser Award for excellence in teaching (1990) and is a Fellow of the American Association for the Advancement of Science (2004).
Loading more stuff…
Hmm…it looks like things are taking a while to load. Try again?